Multicentre randomised trial of screening with sFlt1/PlGF and planned delivery to prevent pre-eclampsia at term: protocol of the PE37 study.

Authors:
Llurba E; Crispi F; Crovetto F; Youssef L; Delgado JL and 16 more

Journal:
BMJ Open

Publication Year: 2024

DOI:
10.1136/bmjopen-2023-076201

PMCID:
PMC10928726

PMID:
38458783

Journal Information

Full Title: BMJ Open

Abbreviation: BMJ Open

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests: Roche Diagnostics International (Switzerland) will provide at no cost the assays for the sFlt-1 and PlGF measurements (Elecsys). EL has received financial support for her presentations from Cook and Roche Diagnostics. JLD has received fees for advisory services from Roche Diagnostics."

Evidence found in paper:

"Funding: JLD and IP have received a grant from the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III, European Regional Development Fund ‘A way of doing Europe’, award number: PI17/01350. Additionally, the project has been partially funded by the Instituto de Salud Carlos III (ISCIII), award number: PI22/00109, cofunded by the European Union; the Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK). Award number: N/A; Roche Diagnostics International Ltd and Roche Diagnostics, SLU award number: N/A."

Evidence found in paper:

"Trial registration number NCT04766866."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025